Consolidated Appropriations Act of 2021: Key Takeaways for Administrators

On Sunday, December 27 the Consolidated Appropriations Act, 2021 was signed into law. The bill contains nearly $1 trillion in COVID-related relief, including temporary relief for several consumer directed, pre-tax benefit account types.

As a result, employers will have the opportunity to review their plan designs and consider adopting certain provisions to provide additional assistance to their employees, including carryover and grace periods for Health FSAs and DCFSA’s, a special carry forward rule for dependent care FSA, prospective changes in elections, plan changes and more.

Foulston Siefkin’s Jason Lacey and Alegeus’ Brian Colburn take a closer look at pertinent components of the Consolidated Appropriations Act 2021 and explore potential impacts and takeaways for consumers, employers, and administrators.

Watch a replay of this webinar to gain a better understanding of what this means for your business.

View webinar

Sign up for our newsletter

Never miss an Alegeus webinar. Sign up to receive updates today!


Related content

View all webinars

The Top 3 Open Enrollment Challenges COBRA Administrators Face This Year - Plus Strategies For Success

COBRA: Best Practices for Relieving Administrative Burden

Top Sales Trends in High-Growth Consumer-Directed Accounts

The biggest mistakes most TPAs make - and how to move past them

Consolidated Appropriations Act of 2021: Key Takeaways for Administrators

2021 Health Benefits Forum: A look ahead to the themes transforming our industry

Simplifying ICHRAs: How to provide a seamless ICHRA and benefits enrollment experience

The Impact of the COVID-19-Induced Economic Crisis on U.S. Health Insurance and Benefits: Navigating Through the Fog

What You Need to Know About IRS Notices 2020-29 & 2020-33: The Impact to Your Business

Assessing the Impact of COVID-19 On Your Benefit Account Administration Business

Provide Financial Stability During the Crisis: Introducing the Employee Care Card from Alegeus

COVID-19: Ask the Regulatory/Compliance Expert